Evidence map›Paper›PMID 28099659›Full record

ArticleRevista de saude publica2016

Factors associated with the use of antihypertensives among seniors.

Kaio Henrique Correa Massa, José Leopoldo Ferreira Antunes, Maria Lúcia Lebrão, Yeda Aparecida Oliveira Duarte, Alexandre Dias Porto Chiavegatto

Abstract read
In one paragraph

Article in Revista de saude publica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kaio Henrique Correa MassaPrograma de Pós-Graduação em Saúde Pública. Faculdade de Saúde Pública. Universidade de São Paulo. São Paulo, SP, Brasil.
José Leopoldo Ferreira AntunesDepartamento de Epidemiologia. Faculdade de Saúde Pública. Universidade de São Paulo. São Paulo, SP, Brasil.
Maria Lúcia LebrãoDepartamento de Epidemiologia. Faculdade de Saúde Pública. Universidade de São Paulo. São Paulo, SP, Brasil.
Yeda Aparecida Oliveira DuarteEscola de Enfermagem. Universidade de São Paulo. São Paulo, SP, Brasil.
Alexandre Dias Porto ChiavegattoDepartamento de Epidemiologia. Faculdade de Saúde Pública. Universidade de São Paulo. São Paulo, SP, Brasil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAnalyze the use of antihypertensives among seniors and the association with socioeconomic and behavioral characteristics.

methodsIn this seriate cross-sectional study, we used data from the Saúde, Bem Estar e Envelhecimento study (SABE - Health, Well-being, and Aging), conducted in 2000, 2006, and 2010 in the city of São Paulo. Association between the use of antihypertensives and the demographic, behavioral, and socioeconomic characteristics and risk factors was analyzed by using multilevel logistic regression models.

resultsWe observed increased proportion of use of antihypertensive, from 48.7% in 2000 to 61.3% in 2006, reaching 65.7% in 2010. Among the seniors who made use of this type of medicine, we also observed increased adoption of combined therapy in the period, from 69.9% to 82.6% from 2000 to 2006 and reaching 91.6% in 2010. Multilevel analysis indicated statistically significant increase in use of antihypertensives, even after control by socioeconomic and behavioral characteristics, both in 2006 and in 2010 (OR = 1.90; 95%CI 1.60-2.24 and OR = 1.94; 95%CI 1.62-2.33, respectively). Use of antihypertensives showed positive association with females, higher age group, black skin color, overweight, and smoking history.

conclusionsHigh use of antihypertensives and its association with sociodemographic and behavioral characteristics can help guide the discussion of strategies to improve the epidemiological situation, the quality of life, and the distribution of medicines to the elderly population. OBJETIVO: Analisar o uso de medicamentos anti-hipertensivos em idosos e a associação com características socioeconômicas e comportamentais. MÉTODOS: Neste estudo transversal seriado, foram utilizados dados do estudo SABE (Saúde, Bem Estar e Envelhecimento), realizado em 2000, 2006 e 2010 no município de São Paulo. A associação entre o uso de medicamentos anti-hipertensivos e as características demográficas, socioeconômicas comportamentais e fatores de risco foi analisada por meio de modelos de regressão logísticos multinível. RESULTADOS: Foi observado aumento da proporção do uso de anti-hipertensivo, de 48,7% em 2000 para 61,3% em 2006, chegando à 65,7% em 2010. Entre os idosos que faziam uso desse tipo de medicamento, também foi observado aumento da adoção da terapia combinada no período, passando de 69,9% para 82,6% de 2000 a 2006 e alcançando 91,6% em 2010. A análise multinível indicou aumento estatisticamente significativo do uso de anti-hipertensivos, mesmo após controle pelas características socioeconômicas e comportamentais, tanto em 2006 como em 2010 (OR = 1,90; IC95% 1,60-2,24 e OR = 1,94; IC95% 1,62-2,33, respectivamente). O uso de anti-hipertensivos apresentou associação positiva com sexo feminino, maior faixa etária, cor da pele preta, sobrepeso e histórico de tabagismo. CONCLUSÕES: O uso elevado de anti-hipertensivos e sua associação com as características sociodemográficas e comportamentais podem ajudar a orientar a discussão de estratégias para a melhoria do quadro epidemiológico, da qualidade de vida, e da distribuição de medicamentos para a população idosa.

Indexed as

AgedAged, 80 and overAge FactorsAntihypertensive AgentsBody Mass IndexBrazilCross-Sectional StudiesFemaleHumansHypertensionLogistic ModelsMaleMiddle AgedRisk FactorsSex FactorsSocioeconomic FactorsAntihypertensive Agents

Identifiers

PMID28099659
PMCPMC5152823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.